← Human Trials & Peer-Reviewed Studies
Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy.
Plain-language guide to PMID 15764170 (2004): clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Key Facts
- PMID
- 15764170
- Journal
- Scandinavian journal of infectious diseases
- Year
- 2004
- Study type
- Clinical Trial
- Authors
- Andersen O et al. (8 authors)
- DOI
- 10.1080/00365540410021162
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a clinical trial.
Three h GH-suppression tests using oral glucose were undertaken to determine dynamics of GH-secretion.
Why It Was Studied
Growth hormone (GH)-secretion in HIV-lipodystrophy is impaired; however, GH-sensitivity of GH-target tissues remains to be evaluated.
The researchers measured overnight fasting concentrations of GH-sensitive insulin-like growth-factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) including GH binding protein (GHBP), a marker of GH-receptor sensitivity, in antiretroviral treated HIV-infected patients with (LIPO) and without lipodystrophy (NONLIPO) and antiretroviral naive HIV-infected patients (NAIVE).
Who Took Part
The age groups tagged for this paper are adults, men only.
What Was Measured
Growth hormone (GH)-secretion in HIV-lipodystrophy is impaired; however, GH-sensitivity of GH-target tissues remains to be evaluated.
The researchers measured overnight fasting concentrations of GH-sensitive insulin-like growth-factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) including GH binding protein (GHBP), a marker of GH-receptor sensitivity, in antiretroviral treated HIV-infected patients with (LIPO) and without lipodystrophy (NONLIPO) and antiretroviral naive HIV-infected patients (NAIVE).
Topics PubMed links to this paper include Absorptiometry, Photon, Antiretroviral Therapy, Highly Active, Body Composition, Glucose, HIV Infections, HIV-Associated Lipodystrophy Syndrome and Human Growth Hormone.
What This Means in Plain Language
This is a clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The publication is from 2004 (Scandinavian journal of infectious diseases), a journal based in England.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.